Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cytokine"
DOI: 10.1016/j.cyto.2018.11.001
Abstract: &NA; Different cardiovascular risk factors present a heterogenic manifestation of lower limb atherosclerosis. The molecular mechanisms behind this phenomenon remain unknown. We aimed to clarify this phenomenon by studying the association of major cardiovascular risk…
read more here.
Keywords:
lower limb;
risk factors;
cardiovascular risk;
major cardiovascular ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwac172
Abstract: AIMS We determined the prevalence of prescription smoking cessation pharmacotherapy (SCP) use after hospitalisation for major cardiovascular disease among people who smoke and whether this varies by sex. METHODS We conducted a population-based cohort study…
read more here.
Keywords:
cardiovascular disease;
smoking cessation;
prescription;
scp ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead251
Abstract: OBJECTIVE To validate the predictive value of the DAS28-γGT for the occurrence of major cardiovascular (CV) events (MACE) in the ESPOIR cohort. METHODS Analysis of 13-year outcome from the ESPOIR cohort. Rheumatoid arthritis (RA) patients…
read more here.
Keywords:
das28;
mace;
espoir cohort;
rheumatoid arthritis ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Critical Care Medicine"
DOI: 10.1097/ccm.0000000000005793
Abstract: OBJECTIVES: To describe risk factors for major cardiovascular events in adults following hospital discharge after sepsis. DESIGN: Population-based cohort study. SETTING: Ontario, Canada (2008–2017). PATIENTS: Adult patients (age 18 yr or older) who survived a…
read more here.
Keywords:
sepsis;
factors major;
risk factors;
major cardiovascular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000002771
Abstract: BACKGROUND There is continuous debate whether chlorthalidone (CTD) and hydrochlorothiazide (HCTZ) differ in reducing major cardiovascular events (MACE). HCTZ is prescribed 10 times more commonly than CTD. METHOD A systematic literature search yielded 14 references,…
read more here.
Keywords:
ctd;
hctz;
ventricular mass;
major cardiovascular ... See more keywords
Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Urology"
DOI: 10.1097/ju.0000000000000943.09
Abstract: hypertension or major cardiovascular events at follow-up (p>0.05). CONCLUSIONS: In patients undergoing RN, the risk of hypertension or major cardiovascular events is predicted by presence of nephropathy, heart failure or history of myocardial infarction, but…
read more here.
Keywords:
hypertension major;
comparative analysis;
pd49 comparative;
analysis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029556
Abstract: Background: The effects of omega-3 fatty acid on cardiovascular health obtained inconsistent results. A systematic review and meta-analysis were therefore conducted to assess the effects of omega-3 fatty acid supplementation for primary and secondary prevention…
read more here.
Keywords:
meta analysis;
fatty acid;
major cardiovascular;
effects omega ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Epilepsia"
DOI: 10.1111/epi.16930
Abstract: This study was undertaken to determine whether epilepsy and antiepileptic drugs (including enzyme‐inducing and non‐enzyme‐inducing drugs) are associated with major cardiovascular events using population‐level, routinely collected data.
read more here.
Keywords:
epilepsy antiepileptic;
drugs risk;
antiepileptic drugs;
major cardiovascular ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Circulation Research"
DOI: 10.1161/circresaha.117.311588
Abstract: Cardiovascular disease (CVD) is a major challenge in the management of type 2 diabetes mellitus. Glucose-lowering agents that reduce the risk of major cardiovascular events would be considered a major advance, as recently reported with…
read more here.
Keywords:
outcome;
lowering agents;
type diabetes;
diabetes mellitus ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Hypertension"
DOI: 10.1161/hypertensionaha.123.20954
Abstract: BACKGROUND Previous meta-analyses using traditional pairwise comparisons did not support intensive systolic blood pressure (SBP) control in patients with diabetes and included trials published before 2015. We aimed to identify the optimal SBP control targets…
read more here.
Keywords:
patients type;
meta;
type diabetes;
major cardiovascular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Cardiovascular Diabetology"
DOI: 10.1186/s12933-017-0609-4
Abstract: BackgroundDiabetes mellitus has long been associated with cardiovascular events. Nevertheless, the higher burden of traditional cardiovascular risk factors reported in high-income countries is offset by a more widespread use of preventive measures and revascularization or…
read more here.
Keywords:
t2dm patients;
myocardial infarction;
hospital;
mortality ... See more keywords